Background and Purpose-The possible neuroprotective effect of endogenous ␥-aminobutyric acid (GABA) on the irreversible electrophysiological changes induced by in vitro ischemia on striatal neurons was investigated. In particular, the aim of the study was the characterization of the neuroprotective action of 2 antiepileptic drugs increasing GABAergic transmission such as tiagabine, a GABA transporter inhibitor, and vigabatrin, an irreversible inhibitor of GABA transaminase. Methods-Extracellular field potential recordings were obtained from rat corticostriatal slice preparations. In vitro ischemia was delivered by switching to an artificial cerebrospinal fluid solution in which glucose was omitted and oxygen was replaced with N 2 . Results-An irreversible loss of the field potentials recorded from striatal neurons was observed after 10 minutes of ischemia in control solution. Conversely, tiagabine and vigabatrin partially prevented the ischemia-induced field potential loss. Surprisingly, both GABA A and GABA B receptor antagonists blocked these effects. Accordingly, neuroprotection could be obtained only when GABA A and GABA B receptor agonists were coapplied, but not when a single agonist was given in isolation. Key Words: anticonvulsants Ⅲ corpus striatum Ⅲ electrophysiology Ⅲ ischemia Ⅲ receptors, GABA C ombined oxygen and glucose deprivation is a wellestablished in vitro model of ischemia for electrophysiological studies. 1-3 The striatum and hippocampus are particularly vulnerable to ischemic insult, and neuronal damage is expressed as an alteration of both intrinsic membrane properties and synaptic transmission of the recorded cells. 4 -6 A large body of experimental work has been devoted to explore the neuroprotective efficacy of drugs blocking glutamate neurotransmission in animal models of cerebral ischemia. 3,[7][8][9][10][11] More recently, however, attention has been also focused on ␥-aminobutyric acid (GABA) changes during ischemia and on possible neuroprotective effects of GABAergic drugs. [12][13][14][15] Although a number of studies have suggested that increasing GABAergic synaptic transmission might display neuroprotective effects against brain ischemia, 16 -20 the exact mechanisms underlying these effects have yet to be elucidated.
Conclusions-AntiepilepticIncreasing GABA function might represent a beneficial therapeutic approach to acute ischemia for different reasons. 13,19,20 First, endogenous GABA synthesis and release with consequent reduction in GABAergic transmission are decreased after an ischemic insult. Second, since glutamatergic and GABAergic transmissions work by each counterbalancing the function of the other, enhancing GABAergic activity should balance excessive glutamatergic excitation, which is the pivotal event leading to cell death.The aim of the present study is to characterize the electrophysiological effects of 2 currently used GABAergic antiepileptic drugs, tiagabine and vigabatrin, and to examine the cellular sites at which they act by using recordings from rat cortico...